Bibliography
- Sarkar DP, Ramani K, Bora RS, et al. Process for producing a targeted gene. US5683866; 1997
- Bhosle D, Bharambe S, Gairola N, Dhaneshwar SS. Mutual prodrug concept: fundamentals and applications. Indian J Pharm Sci 2006;68:286-94
- Examination guidelines for determining obviousness under 35 USC 103 in view of the Supreme Court decision in KSR International Co. v. Teleflex, Inc. Fed Reg 2007;72(195):57526-35
- Breschi MC, Calderone V, Digiacomo M, et al. NO-sartans: a new class of pharmacodynamic hybrids as cardiovascular drugs. J Med Chem 2004;47(23):5597-600
- Hanson RN, Babich JW. Polypharmacophoric agents. US7141573; 2006
- Weaver DF, Carran JR. Anti-epileptogenic agents. US6930112; 2005
- Rosen N, Danishefsky S, Ouerfelli O, et al. Methods and compositions for destruction of selected proteins. US6670348; 2003
- Hulsman N, Medema JP, Bos C, et al. Chemical insights in the concept of hybrid drugs: the antitumor effect of nitric oxide-donating aspirin involves a quinone methide but not nitric oxide nor aspirin. J Med Chem 2007;50:2424-31